Aim: Our previous study confirmed the defect of B7-H4 expression in peripheral blood and salivary glands of patients with primary Sj€ ogren's syndrome (pSS). The aim of this study was to analyze the effect of the deficit expression of B7-H4 on CD4 + T cells.
INTRODUCTION
Primary Sj€ ogren's syndrome (pSS), a chronic autoimmune disorder, primarily targets lacrimal and salivary glands, resulting in loss of gland secretory functions. 1 The pathogenesis of SS is not fully defined, but is related to the massive lymphocytic infiltration in the exocrine gland that is a hallmark of pSS. 1, 2 Because of the widespread involvement of various epithelial cells, pSS has also been described as autoimmune epithelitis. 3, 4 Salivary gland epithelial cells (SGEC) are able to present antigens and play an important role as initiators of T cell responses or as targets attacked by T cells in immune salivary gland lesions in pSS. [5] [6] [7] B7-H4, also known as B7x or B7s1, is a member of the B7 superfamily. [8] [9] [10] [11] The important role of B7-H4 in down-regulation of antigen-specific T cell immune responses is to induce cell cycle arrest and to inhibit cytokine secretion and T cell proliferation.
elucidation of the precise role of B7 expression in parenchymal epithelial cells is particularly important for understanding the pathophysiology of autoimmune disorders including pSS. In our previous study, we demonstrated that patients with pSS had the deficit expression of B7-H4 both in peripheral blood and salivary glands. In salivary glands, B7-H4 are dominantly expressed by SGECs. 16 Given that epithelia cells can act as antigen presenting cells, we come up with the hypothesis that B7-H4 deficiency in SGECs of pSS patients causes the lack of suppression of infiltrating CD4 + T, resulting in local inflammation. Here, in vitro, we cultured purified CD4 + cells with SGECs to detect the proliferation change and cytokine secretion caused by B7-H4 expressed by SGECs.
MATERIALS AND METHODS

Patients and samples
Six newly diagnosed patients with pSS referred to the Department of Rheumatology and Immunology at Anhui Provincial Hospital, China, were enrolled. All patients were diagnosed according to criteria established by the American-European Consensus Group, including presence of positive anti-SSA (Sj€ ogren's syndrome antigen A)/SSB antibodies or focus score ≥ 1.
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None of the patients studied had received glucocorticoid and/or immunosuppressive drug treatment before the biopsy. Salivary gland biopsies were obtained at the time of the surgical excision of the salivary gland tissue from pSS patients, half of which were sent for pathology and the rest for SGEC purification and cell culture. Five specimens contained moderate (one lymphocytic focus) and one contained extensive (≥ 2 lymphocytic foci) periductal lymphocyte foci. For comparison, labial glands were excised from six non-SS sicca syndrome patients. The six patients had sicca symptoms but did not fulfill the standard of pSS diagnosis (without any feature of autoimmunity: no autoantibodies, no salivary gland lymphocytic infiltrate). Another six agematched healthy controls were enrolled. All subjects gave their informed consent and the study was approved by the Ethics Committee of Anhui Provincial Hospital.
Clinical and laboratory profiles
Clinical examinations and serological tests were taken by all the pSS patients. Demographic data and clinical manifestations were collected. Antinuclear antibody (ANA), anti-SSA/Ro 52 antibodies, anti-SSB antibodies and rheumatoid factor (RF) were measured by the clinical laboratory. In detail, ANA was determined by immunofluorescence, and RF was detected by nephelometry. Dot immunobinding assay was used to detect serum anti-SSA and anti-SSB. Table 1 shows the patient characteristics.
Purification of salivary gland epithelial cells
Salivary gland cells harvested from the lower lip were cultured according to the explant outgrowth technique. 18 Briefly, the lobule was washed with cold sterile phosphate-buffered saline (PBS) and cut into 0.5 mm 3 small fragment. The little fragments were then placed into 75 cm 2 flasks with 3 : 1 mixture of Ham's F-12 and Dulbecco's modified Eagle's medium supplemented with 2.5% fetal calf serum (FCS) (all purchased from Life Technologies, Grand Island, NY, USA), epidermal growth factor (Millipore, Billerica, MA, USA; 10 ng/mL), hydrocortisone (Stemcell Technologies, Vancouver, BC, Canada; 0.4 mg/mL), insulin (Life Technologies; 0.5 mg/mL), penicillin (100 U/mL) and streptomycin (100 U/mL; Cellgro, Manassas, VA, USA) and were incubated at 37°C. Cultures were fed with fresh medium every 5 days. After 2 weeks, the epithelial cell outgrowth was assessed. Cells at 70-80% confluence were dissociated with 0.25% trypsin-ethylenediaiminetetraacetic acid (Life Technologies) and subcultured on type I collagen (Sigma-Aldrich, St. Louis, MO, USA) coated 24-well plates (6 9 10 4 cells/well; Cellgro). 
Purification of CD4 + T lymphocytes
Venous blood was collected from healthy controls. Peripheral blood mononuclear cells (PBMC) were isolated by Lymphocyte Separation Medium (Solarbio, Beijing, China). CD4 + T lymphocytes were purified by positive magnetic selection with anti-human CD4 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany; purity > 96% by fluorescent-activated cell sorter [FACS] ). The purified CD4 + T cells were labeled with carboxyfluorescein succinimidyl ester (CFSE; 5 lmol/ L), a dye which can cross intact cell membranes (Invitrogen, Carlsbad, CA, USA) and then washed.
Cocultures of CD4
+ T cells and SGECs + T cells were gated with FSC (forward scatter) versus SSC (sideward scatter) to exclude contaminated SGECs and followed by the CD4 + gating to specifically identify the CD4 + T cells. Then the intensity of CFSE was evaluated to elucidate the proliferation of CD4 + T cells. The decline of the concentration of CFSE after each divide appears as the peaks of the histogram. Each peak represents one generation. The percentages of the proliferated cells in the final culture system were used to assess the proliferation.
Cytokine assessment
Supernatant from the previously mentioned culture system was collected at the time proliferation was detected. To determine the concentration of cytokines, human Th1/Th2/Th9/Th17/Th22 plex Kit FlowCytomix (eBioscience) was used following the product instructions.
Statistical analysis
All data are expressed as means AE standard deviation of the mean (SD) as appropriate. SPSS 13.0 statistical analysis program was used SPSS Inc., Chicago, IL, USA). Statistical comparisons of different groups were made by analysis of variance and significant difference was found among the four groups. Then Bonferroni's pair-wise multiple comparison test was performed to find the differences between groups. P < 0.05 was considered statistically significant.
RESULTS
SGECs suppressed T cell proliferation through B7-H4
To investigate the proliferation response of CD4 + T cells against B7-H4 in cultured SGECs, we evaluated the proliferation of CD4 + T cells from healthy controls cultured with SGECs from non-SS sicca syndrome and pSS in vitro. Figure 1 shows that the proliferation of CD4 + T cells was suppressed by SGECs from patients with non-SS. SGECs from patients with pSS also suppressed the proliferation of CD4 + T cells, but to a much reduced extent compared to that from non-SS sicca syndrome controls. Moreover, when we blocked the B7-H4 expression on SGEC using blocking antibody, the proliferation of CD4 + T cells was increased significantly compared to that of CD4 + T cells cultured with B7-H4-SGECs from patients with non-SS, and reaching the level in CD4 + T cells cultured alone.
SGECs suppressed Th2 cytokine secretion by T cells through B7-H4
Given that B7-H4 affects cytokine secretion of T cells in vitro, here we evaluated the change of cytokine production of CD4 + T cells by SGECs. By detecting the cytokine concentration by FACS after 72 h in the culture system cited earlier, we found that Th2 cytokines, interleukin (IL)-5 and IL-13 were suppressed by adding the SGECs from non-SS patients to the culture system (IL-5: 519.70 AE 73.83 pg/mL, 81.83 AE 8.13 pg/mL; IL-13: 1300.00 AE 213.80 pg/mL, 135.20 AE 23.00 pg/ mL). To prove that this effect is via B7-H4 expressed on SGECs, we added the anti-B7-H4 blocking antibody and the concentrations came up to the level of baseline (IL-5: 552.00 AE 227.20 pg/mL, IL-13: 1433.00 AE 141.00 pg/mL). In addition, T cells cultured with SGECs from SS patients expressing less B7-H4 secreted more IL-5 and IL-13 compared to that with non-SS patients (IL-5: 324.30 AE 144.60 pg/mL, IL-13: 1048 AE 288.50 pg/mL; Fig. 2a,b) . The same changes were found in the concentrations of TH17 cytokines, IL-17A (alone: 1310 AE 94.85 pg/mL; SEGC (non-pSS): 492.3 AE 27.32 pg/mL; +SEGC (pSS): 800.2 AE 34.54 pg/mL; +SEGC (non-pSS) + blocking antibody: 1150 AE 81.08 pg/mL) and IL-6 (alone: 3280 AE 454.3 pg/ mL; SEGC (non-pSS): 1779 AE 243 pg/mL; +SEGC (pSS): 2111 AE 152.3 pg/mL; +SEGC (non-pSS) + blocking antibody: 2808 AE 272.8 pg/mL). However, adding the anti-B7-H4 blocking antibody did not statistically significantly reverse the suppression of IL-6 secretion by SGEC (Fig. 2c,d) . No changes were found in the production of IL-2, IL-9, IL-10 and IL-22 and Th1 cytokine interferon-c (IFN-c; data not shown).
DISCUSSION
Despite extensive study of the underlying cause of pSS, the pathogenesis of pSS remains unclear. The prominent histopathological change is an extensive lymphocytic infiltration in salivary and lachrymal glands, and the majority of infiltrating cells in the salivary glands of SS patients are T cells, predominantly CD4 + T cells. 2, 19 Currently, attention of researchers has focused on subsets of CD4 + T cells, including Th1, Th17 cells and Tregs cells, and their function. 2 However, few studies have centred on the interaction between T cell activation and SGECs in pSS. In fact, as early as 1999, the expression of B7 family costimulatory molecules has been found on SGECs in pSS patients, including B7.1 and B7.2, indicating the activate status of the cells. 20 Later studies from the same research group proved constitutive expression of B7.2 molecules is sufficient to provide costimulatory signals to anti-CD3-stimulated T cells, implying a critical role for epithelial cells in the regulation of local immune responses in the salivary glands. 21, 22 Evidence of the involvement of B7-H4 in the pathogenesis of various autoimmune disorders has been reported. 15 In our previous study, we found B7-H4 was not expressed on lymphocytes but on SGECs and the expression in pSS patients was lower than that in nonpSS controls, 16 adding the defect of B7-H4 expression on SGECs to the infiltration of lymphocytes. Given that high expression of B7.1 and B7.2 proteins by the SG epithelia in SS patients might work for presenting antigens to T cells during the development of the lymphoepithelial lesions, 20 there may be possible interactions between B7-H4 on SGECs and infiltrating T cells.
To explore the effect of B7-H4 expressing SGECs on T cells, we cultured SGECs with T cells. Of note, proliferation of CD4 + T cells co-cultured with SGECs obtained from patients with non-SS was significantly inhibited. Meanwhile, SGECs from pSS patients suppressed less than that from non-SS patients, which was consistent with the lower expression of B7-H4. The rescue of the proliferation by adding B7-H4 blocking antibodies verified the suppressive effect was mediated by B7-H4. In fact, B7-H4 was proven to inhibit T cell proliferation when it was first identified, 10 but that was in mice. Later on, Chen et al. demonstrated human renal tubular epithelial cells (TECs) related to B7-H4 promoted the proliferation of co-cultured T cells instead of inhibiting them. Their results were inconsistent with the concept of an overall negative regulatory function for B7-H4 in T-cell activation and the authors thought it was specific in TEC-mediated immune action, 14 whereas we demonstrated here in salivary glands, SGEC-related B7-H4 acted with the overall suppressive function. In this regard, the reduced expression of B7-H4 in salivary gland tissues along with soluble B7-H4 in serum 16 in the pSS patients may reduce their capability of inhibiting activation and proliferation of T cells; at the same time, the over-expression of B7.1 and B7.2 on SGECs present the positive signal to activate the infiltrating T cells, 20 leading to massive T cell accumulation in lesions of diseased lacrimal and salivary glands.
On the other hand, the secretion of IL-13 and IL-5 in the supernatant was significantly suppressed by SGECsrelated B7-H4. As known, IL-13 and IL-5, which are Th2 cytokines, induce proliferation and differentiation of B cells. 23 Also, the increase of IL-13 has been reported in human SS patients. 24 Furthermore, it has been reported in mice that neutralization of IL-13 in mice already suffering from gland impairment was sufficient to improve gland function 25 and the subsequent study proved that elevated levels of IL-13 are due to aberrant production of IL-13 by T cells, indicating a critical role for IL-13 in SS. 26 Therefore, the reduced expression of B7-H4 in salivary gland tissues may contribute to autoantibody production by accelerating B cell differentiation with reduction of IL-13 and IL-5, another mechanism related to the pathogenesis of pSS. In addition to Th2 response, Th17 was also proven to be increased both in plasma and the salivary gland.
27 Similarly, the level of IL-17A and IL-6 in supernatant decreased when SGECs were present. IL-17A levels went up when B7-H4 was blocked. Although no difference in IL-6 level was found while comparing the B7-H4 blocking antibody group to the pSS SGCEs group, we could still saw the trend recovering. In fact, historically, pSS was thought to be a Th1-driven disease due to the predominance of IFN-c producing cells, in target organs and peripheral blood of these patients, whereas in this study, we did not find changes in IFN-c in the culture system whether B7-H4 is present or not, and as well as other cytokines including IL-2, IL-9, IL-10 and IL-22.
In conclusion, in addition to what we found before that B7-H4 costimulatory molecule expression was deceased on SGECs and in serum of patients with pSS, we explain here that the decreased expression of B7-H4 and soluble B7-H4 downgrades the suppression of T cell activation and proliferation as well as the suppression of IL-13, IL-5, IL-17A, IL-6 secretion. Collaborating with B7.1 and B7.2, B7-H4 may partly contribute to the pathogenesis of pSS. To more strongly prove this, higher volumes of samples are needed. Meanwhile, using the infiltrated T cells instead of the T cells purified from peripheral blood will more directly and powerfully confirm our findings.
